Table: Towa Pharmaceutical -2019/20 group results

TOWA PHARMACEUTICAL

14/05/2020 07:00

May 14 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            110.38          105.10         150.00        72.80    
                 (+5.0 pct)      (+12.5 pct)    (+35.9 pct)  (+31.5 pct) 
  Operating         16.14           15.97          14.30         7.00    
                 (+1.1 pct)      (+37.1 pct)    (-11.4 pct)  (-24.1 pct) 
  Recurring         20.99           18.87          14.80         7.30    
                 (+11.3 pct)     (+61.0 pct)    (-29.5 pct)  (-25.0 pct) 
  Net
  Net               14.50           13.48          10.40         5.10    
                 (+7.6 pct)     (+107.5 pct)    (-28.3 pct)  (-27.8 pct) 
  EPS            294.74 yen      273.85 yen     211.34 yen    103.64 yen 
  EPS Diluted    272.62 yen      253.32 yen                              
  Ann Div         44.00 yen      107.50 yen      44.00 yen               
  -Q2 Div         22.00 yen       47.50 yen      22.00 yen               
  -Q4 Div         22.00 yen       60.00 yen      22.00 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T